Substance use is a concern for people with a mental illness due to the association with poor clinical and social outcomes. Substance use places additional burden on patients, families, psychiatric services, and government resources due to high rates of treatment non-adherence and relapse.

Substance abuse leads to risk-taking behaviour, illegal activity, interpersonal problems and a loss of interest in usual activities. Abuse jeopardises physical health and neglect of important commitments at home, school or work.

Substance dependence involves having a strong physical or psychological need for the substance. Not taking it leads to withdrawal symptoms within a few hours of stopping, such as nausea, vomiting, tremors, chills, sweating, low blood pressure, irritability, depression, anxiety or confused thinking.

What is the evidence for substance use in people with bipolar disorder?

Moderate to low quality evidence finds a medium to large increased risk of any substance use disorder in people with bipolar disorder compared to people without a mood disorder. Moderate to high quality evidence shows people with a comorbid substance use disorder have more manic episodes, and are more likely to have a diagnosis of bipolar I rather than bipolar II disorder. They are also more likely to be male, have a history of suicidal behaviour, and have an early age of onset of bipolar disorder (<18 years). Having a substance use disorder was also associated with a greater risk of hospitalisation, high levels of alcohol intake, increased the risk of a mood recurrence and rapid-cycling.

For cannabis use in particular, moderate quality evidence found around one-quarter of people with bipolar disorder reported using cannabis. Cannabis use was associated with more depression, anxiety, and mania symptom severity, more mood episodes, more suicide attempts, and more insomnia or hypersomnia. Cannabis use was also associated with younger age, male gender, single marital status, having fewer years of education, an earlier onset of affective symptoms, psychotic symptoms, and use of other substances.

In children and youth with bipolar disorder, moderate to low quality evidence finds the risk of having a substance use disorder is around 31%. Rates were significantly higher in youth than in children, and in youth with comorbid PTSD or disruptive behaviour disorder.

November 2021

Image: ©Photographee.eu – Fotolia – stock.adobe.com

The post Drug and alcohol use appeared first on NeuRA Library.

Tobacco smoking is very common among people with a mental illness, who often show particularly heavy use. This poses considerable health risks, potential interference with the metabolism of medications, as well as financial burden for the individual. Heavy cigarette use may contribute to increased mortality and reduced life expectancy.

What is the evidence for smoking?

Moderate to high quality evidence suggests small to medium-sized, increased rate of smoking in people with bipolar disorder compared to the general population, and compared to people with major depression. There was a small decreased rate of smoking in people with bipolar disorder compared to people with schizophrenia.

Moderate to low quality evidence suggests varenicline (champix/chantix) may reduce rates of smoking.

October 2021

Image: ©ehabeljean – Fotolia- stock.adobe.com

The post Smoking appeared first on NeuRA Library.